Banner BF Platform

The partnering platform to pre-organise one-to-one meetings with the BioFIT participants is open!

Don’t hesitate to go make the best use out of it to leverage your time on site:

Go fill in your profile with the maximum of keywords on the platform (and make sure to publish it in order to be visible to other participants) and start sending meeting requests.

This is the perfect opportunity to create collaborations!

 

Welcome Reception

Arriving in Lille on December 3rdDiscover the charm of the city of Lille during Christmas time

The Welcoming Party will take place in the Omnia bar (9, rue Esquermoise, Lille) on December 3rd from 6.30 pm. What’s planned? Drinks, tapas and a ferris wheel ride to admire Lille from above!
[/vc_column_text]

Registration for the Welcome Reception is free. Register now by completing the form below:

[/vc_column][/vc_row]

December 5th 2018
10.30 am – 12.30 pm
Lille, France

EDCA invites you to a round table during BioFIT to exchange on the hot topic of the new European In Vitro Diagnostic Regulation.

About EDCA:

European Diagnostic Clusters Alliance – EDCA is the first European network serving the competitiveness of the medical diagnostic industry. It federates 8 European clusters and counts 350 companies.

The purpose of EDCA is:

  • To promote competitiveness of European industry in the area of medical diagnosis. The association will enhance the synergies between academic research, clinical research, health authorities and diagnostic companies;
  • To ease the growth of European SMEs in medical diagnostic;
  • To promote the development of diagnostic clusters and competitiveness clusters in Europe;
  • To promote cooperation between diagnostic clusters (inter-cluster) in order to help build European collaborative projects.

EDCA members:

  • BioTurku (Finland)
  • BioWales (United Kingdom)
  • BioWin (Belgium)
  • Eurobiomed (France)
  • Heath Capital (Germany)
  • Medicen (France)
  • The Oxford AHSN (United Kingdom)
  • Uppsala Bio (Sweden)

Many thanks to Ferring for joining BioFIT 2018 as a Silver Sponsor

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company’s research and development investment goes towards finding innovative and personalised healthcare solutions to help mothers and babies, from conception to birth.

Join key BioFIT 2018 sponsors such as PfizerBayerRocheMSDBoehringer IngelheimLFBGENFIT, VIB, Ferring Pharmaceuticals and Sanofi to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Discover who will be attending:

ALMIRALL S.A.
BAYER HEALTHCARE
BOEHRINGER INGELHEIM
EA PHARMA CO., LTD.
ELANCO
FERRING PHARMACEUTICALS
GSK – GLAXOSMITHKLINE
IPSEN INNOVATION
JOHNSON & JOHNSON
JT PHARMA
LEO PHARMA A/S
LFB
LILLY
MARUHO CO.
MERCK
MOCHIDA PHARMACEUTICAL CO., LTD.
MSD
NOVO NORDISK
PFIZER
ROCHE
SANOFI
SERVIER
SUMITOMO DAINIPPON PHARMA
VIRBAC
ZOETIS

Many thanks to Sanofi for joining BioFIT 2018 as a Gold Sponsor!

Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people they serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare.

Join key BioFIT 2018 sponsors such as PfizerBayerRocheMSDBoehringer IngelheimLFBGENFIT, VIB and Sanofi to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

PARTNERING DAY
December 3rd, 2018

Fostering Innovation

Boehringer Ingelheim knows what it takes to be innovative and entrepreneurial. From the small factory in 1885 to today’s global pharmaceutical organisation, we know how important it is to nurture and develop emerging science and technology.
Our track record of bringing breakthrough medicines to patients starts with new ideas and new science, and collaborations with external partners play a key role in helping us deliver an innovation-led portfolio. Join us at our partnering day to explore how we can develop the next generation of medicines together.
For more information on our partnering interests please visit: www.boehringer-ingelheim.com/partnering/interests.

Meet our research and partnering team

Research and partnering teams will be available throughtout the day for networking.

Register to attend and apply for a one-to-one meeting

Register to attend the event and, if interested, apply for a one-to-one meeting to discuss potential opportunities for partnering with our team.

Deadline: 1st November

Many thanks to GENFIT for joining BioFIT 2018 as a Bronze Sponsor!

GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diangostics solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology.

Join key BioFIT 2018 sponsors such as PfizerBayerRocheMSDBoehringer IngelheimLFB, GENFIT and VIB to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

They were the BioFIT 2017 sponsors: Sanofi, Pfizer, Bayer, Genfit, Lilly, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni.

For more information about the sponsorship opportunities, visit the dedicated site page.

The European Genomic Institute for Diabetes (EGID) will host its 5th international symposium: the gut, incretins and diabetes, from December 4th, 2018, Lille.

This biennial event brings an international focus to our work by the joining of the IDEA Summit and the EGID symposium.
The committee and speakers are world leaders in their fields and will present the latest scientific advances in diabetes and related disorders.
This symposium provides an opportunity for young researchers to present their work via poster presentation and to win the “Best Poster Award” of up to 1000 euros.

Conference Programme:

8.30 – 9.15 AM
WELCOME COFFEE & SYMPOSIUM MATERIAL DISTRIBUTION

9.15 – 9.30 AM
INTRODUCTION AND WELCOMING

9.30 – 10.15 AM
INSIGHTS FROM BARIATRIC SURGERY

RACHEL BATTERHAM
Professor of Obesity, Diabetes and Endocrinology – NIHR Research Professor, Head of UCLH Obesity & Bariatric Services, Head of Center for Obesity Research, Department of Medicine, Rayne Building, University College London

10.15 – 11.00 AM
FOOD AND TYPE 2 DIABETES: RESTORING THE INSIDE OF THE SYSTEM

ROY TAYLOR
Professor of Medicine and Metabolism, Magnetic Resonance Centre, Campus for Ageing and Vitality, Newcastle upon Tyne

11.00 – 11.30 AM
EGID POSTER SESSION

11.30 AM – 1.00 PM
BIOFIT PLENARY SESSION: Seed funds crossing borders: How far and how fast is the early-stage investment market in Biotech globalising?

1:00 PM – 2.30 PM
LUNCH

2.30 – 3.15 PM
INCRETINS, DIABETES AND CV DISEASE

NIKOLAUS MARX
Director of the Medical Cardiology Clinic – Cardiology, pneumonology, angiology, internal intensive care Aachen University Hospital

3.15 – 4.00 PM
GUT-BRAIN GLUCOSE SIGNALING IN THE CONTROL OF ENERGY HOMEOSTASIS

GILLES MITHIEUX
Research Director – CNRS Director of U1213, Nutrition, Diabetes and the Brain

4.00 – 4.30 PM
NETWORKING BREAK

4.30 – 5.15 PM
THERAPEUTIC POTENTIAL OF MULTI-INCRETIN THERAPY – FROM MICE TO MEN

AIMO KANNT
Head of Department, General Metabolism & Obesity, Sanofi

5.15 – 5.30 PM
BEST PAPER AWARD

5.30 – 6.00 PM
CONCLUSION & INVITATION TO THE CHEESE AND WINE COCKTAIL

Partners: